OCS
Oculis Holding AG Ordinary shares
NASDAQ: OCS · HEALTHCARE · BIOTECHNOLOGY
$27.48
+3.89% today
Updated 2026-04-30
Market cap
$1.57B
P/E ratio
—
P/S ratio
1,311.54x
EPS (TTM)
$-2.40
Dividend yield
—
52W range
$16 – $31
Volume
0.4M
Oculis Holding AG Ordinary shares (OCS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-12.03M | $-13.82M | $-25.07M | $-53.84M | $-47.50M | $-62.22M |
| Capital expenditures | $19000.00 | $28000.00 | $3.55M | $48000.00 | $230000.00 | $287470.00 |
| Depreciation | $228000.00 | $235000.00 | $299000.00 | $287000.00 | $406000.00 | — |
| Stock-based comp | $328000.00 | $328000.00 | $804000.00 | $3.61M | $9.78M | $16.04M |
| Free cash flow | $-12.05M | $-13.85M | $-28.62M | $-53.89M | $-47.73M | $-62.51M |
| Investing cash flow | $-19000.00 | $-28000.00 | $-3.55M | $-54.21M | $-17.56M | — |
| Financing cash flow | $4.86M | $55.19M | $1.71M | $129.67M | $54.03M | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |